PMGC Holdings (ELAB) Stock:Surge as NorthStrive Expands Patent Push Into Space Health

TLDR PMGC rises 4.43% as NorthStrive expands its patent strategy into space health. NorthStrive files patents for EL-22 and EL-32 targeting microgravity muscle loss. EL-22 targets myostatin while EL-32 targets myostatin and activin A pathways. New filings cover dosing, delivery methods, combinations, and spaceflight patients. EL-22 and EL-32 remain preclinical with no approvals or microgravity [...]

The post PMGC Holdings (ELAB) Stock:Surge as NorthStrive Expands Patent Push Into Space Health appeared first on Blockonomi.